These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30139520)

  • 1. Corrigendum to 'Revisit the effect of fibrillization on functions of prion protein from the perspective of Cu(II) binding' [Biochem. Biophys. Res. Commun. vol. 503 (1) (3 September 2018) 32-37].
    Qi X; McGuirl M
    Biochem Biophys Res Commun; 2018 Sep; 504(1):359. PubMed ID: 30139520
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to 'The C-terminus of ubiquitin plays a critical role in deamidase Lpg2148 recognition.' [Biochem. Biophys. Res. Commun. 503(4), 18 September 2018, 2943-2948].
    Zhu M; Ma X; Gao Y; Li X; Ke J; Khan MH; Teng M; Ge H; Zhu Z; Niu L
    Biochem Biophys Res Commun; 2018 Oct; 505(2):633. PubMed ID: 30243727
    [No Abstract]   [Full Text] [Related]  

  • 3. Revisit the effect of fibrillization on functions of prion protein from the perspective of Cu(II) binding.
    Qi X; McGuirl M
    Biochem Biophys Res Commun; 2018 Sep; 503(1):32-37. PubMed ID: 29807014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Functional loss of TAGLN inhibits tumor growth and increases chemosensitivity of non-small cell lung cancer" [Biochem. Biophys. Res. Commun. 529 (4) (3 September 2020) 1086-1093].
    Fu J; Wang X; Yue Q
    Biochem Biophys Res Commun; 2021 Feb; 541():102. PubMed ID: 33478719
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "A transient post-translational modification of active site cysteine alters binding properties of the parkinsonism protein DJ-1" [Biochem. Biophys. Res. Commun. 504 (1) (2018 Sep 26) 328-333].
    Mussakhmetov A; Shumilin IA; Nugmanova R; Shabalin IG; Baizhumanov T; Toibazar D; Khassenov B; Minor W; Utepbergenov D
    Biochem Biophys Res Commun; 2018 Nov; 505(3):747. PubMed ID: 30293683
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to 'Soluble FLT-1 rules placental destiny' [Biochem. Biophys. Res. Commun. 46 (2018) 1243-1249].
    Yamashita M; Kumasawa K; Nakamura H; Kimura T
    Biochem Biophys Res Commun; 2018 Jun; 501(2):605-606. PubMed ID: 29753561
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Nanoelectroablation therapy for murine basal cell carcinoma" [Biochem. Biophys. Res. Commun. 424 (2012) 446-450].
    Nuccitelli R; Tran K; Athos B; Kreis M; Nuccitelli P; Chang KS; Epstein EH; Tang JY
    Biochem Biophys Res Commun; 2016 Nov; 480(2):288. PubMed ID: 27793303
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Luciferase of the Japanese syllid polychaete Odontosyllis undecimdonta" [Biochem. Biophys. Res. Commun. 2018 Jul 20;502(3):318-323].
    Schultz DT; Kotlobay AA; Ziganshin R; Bannikov A; Markina NM; Chepurnyh TV; Shakhova ES; Palkina K; Haddock SHD; Yampolsky IV; Oba Y
    Biochem Biophys Res Commun; 2018 Sep; 503(2):1179. PubMed ID: 29954603
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Human GRP78 affinity towards its signaling partners Ire1α and PERK is differently modulated by an unfolded protein client" [Biochem. Biophys. Res. Commun. 487 (2) (2017) 375-380].
    Stan RC; Silva RL; de Camargo MM
    Biochem Biophys Res Commun; 2017 Aug; 490(1):69. PubMed ID: 28601239
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Chlorambucil-conjugated PI-polyamide (Chb-M'), a transcription inhibitor of the RUNX family, has anti-tumor activity against SHH-type medulloblastoma with p53 mutation" [Biochem. Biophys. Res. Commun. 620 (10 September 2022) 150-157].
    Matsui Y; Mineharu Y; Noguchi Y; Hattori EY; Kubota H; Hirata M; Miyamoto S; Sugiyama H; Arakawa Y; Kamikubo Y
    Biochem Biophys Res Commun; 2023 May; 656():146-147. PubMed ID: 36966045
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "RNCR3: A regulator of diabetes mellitus-related retinal microvascular dysfunction" [Biochem. Biophys. Res. Commun. 482 (2017) 777-783].
    Shan K; Li CP; Liu C; Liu X; Yan B
    Biochem Biophys Res Commun; 2017 Dec; 494(3-4):744. PubMed ID: 29110876
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42" [Biochem. Biophys. Res. Commun. 472 (1) (2016) 262-9].
    Chou J; Wang B; Zheng T; Li X; Zheng L; Hu J; Zhang Y; Xing Y; Xi T
    Biochem Biophys Res Commun; 2020 Jan; 521(2):541-543. PubMed ID: 31708098
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Spatial localisation of Discoidin Domain Receptor 2 (DDR2) signalling is dependent on its collagen binding and kinase activity" [Biochem. Biophys. Res. Commun. 501 (1) (18 June 2018) 124-130].
    Luczynski MT; Harrison PT; Lima N; Krasny L; Paul A; Huang PH
    Biochem Biophys Res Commun; 2018 Sep; 504(1):360. PubMed ID: 30143260
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "LncRNA LOC730101 promotes osteosarcoma cell survival under energy stress" [Biochem. Biophys. Res. Commun. 496 (1) (2018) 1-6].
    Cheng G; Li B; Sun X; Cao Z; Zhang G; Zhao Z; Zhao Y; Yu Q; Liu W
    Biochem Biophys Res Commun; 2018 May; 499(2):396. PubMed ID: 29602573
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity" [Biochem. Biophys. Res. Commun. 496 (1) (2018 Jan 29) 76-82].
    Yin K; Dang S; Cui L; Fan X; Xie R; Qu J; Shang M; Chen J
    Biochem Biophys Res Commun; 2018 Mar; 498(1):262. PubMed ID: 29506865
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "β-arrestins negatively control human adrenomedullin type 1-receptor internalization" [Biochem. Biophys. Res. Commun. 487 (2) (2017) 438-443].
    Kuwasako K; Kitamura K; Nagata S; Sekiguchi T; Jiang D; Murakami M; Hattori Y; Kato J
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1139. PubMed ID: 28610829
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Modelling urea-cycle disorder citrullinemia type 1 with disease-specific iPSCs" [Biochem. Biophys. Res. Commun. 486(3) (2017) 613-619].
    Yoshitoshi-Uebayashi EY; Toyoda T; Yasuda K; Kotaka M; Nomoto K; Okita K; Yasuchika K; Okamoto S; Takubo N; Nishikubo T; Soga T; Uemoto S; Osafune K
    Biochem Biophys Res Commun; 2017 Jul; 488(3):570-571. PubMed ID: 28528898
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "A combination of small molecules directly reprograms mouse fibroblasts into neural stem cells" [Biochem. Biophys. Res. Commun. 476 (2016) 42-48].
    Zheng J; Choi KA; Kang PJ; Hyeon S; Kwon S; Moon JH; Hwang I; Kim YI; Kim YS; Yoon BS; Park G; Lee J; Hong S; You S
    Biochem Biophys Res Commun; 2017 Apr; 485(3):705. PubMed ID: 28237361
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Short chain fatty acids induce UCP2-mediated autophagy in hepatic cells" [Biochem. Biophys. Res. Commun. 480 (2016) 461-467].
    Iannucci LF; Sun J; Singh BK; Zhou J; Kaddai VA; Lanni A; Yen PM; Sinha RA
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1517. PubMed ID: 27899181
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Uncovering the underlying physical mechanism for cancer-immunity of MHC class I diversity". [Biochem. Biophys. Res. Commun. 504 (2018) 532-537.
    Li W; Wang J
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):526. PubMed ID: 30420283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.